The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
|Articles|February 2, 2015
- Pharmaceutical Technology-02-02-2015
- Volume 39
- Issue 2
Ross Disperser Maintains Consistency
Ross Bow Tie Dispersers, or High Viscosity Dispersers, are heavy-duty mixers designed for heavy pastes and viscous liquids.
Ross Bow Tie Dispersers, or High Viscosity Dispersers, are heavy-duty mixers designed for heavy pastes and viscous liquids up to several hundred thousand centipoise, with stainless steel 304 wetted parts. An explosion-proof inverter-duty motor helps the mixers incorporate solids into liquid vehicles in a consistent manner without running at high speeds.
An air/oil hydraulic lift raises and lowers the agitator into the vessel, and the mixer features safety limit switches to prevent operation while in the raised position or without a vessel in place. The mixer can be equipped with a vacuum-rated mix vessel with heating/cooling jacket, thermocouple, sight/charge ports on the vessel cover, and caster wheels for ease of movement.
Ross, Charles & Son Company
Articles in this issue
over 11 years ago
Hiden Analytical Combination Spectrometer Increases Repeatabilityover 11 years ago
Radio Frequency Dryer Improves Efficiencyover 11 years ago
FANUC Robot Enhances Cycles Per Secondover 11 years ago
Preventing Tablet Tooling Problemsover 11 years ago
Chiral Resolution with and without Resolving Agentsover 11 years ago
FDA Sets Agenda for 2015 Guidance Developmentover 11 years ago
Cures Require Compromiseover 11 years ago
Ligand-Binding Assays and the Determination of Biosimilarityover 11 years ago
Labeling of Biosimilarsover 11 years ago
FDA Sets Policies to Enhance Drug Security and SafetyRelated to this article
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.